APIs para pesquisa e impurezas

Applications Naturally occurring flavonic glycoside; rhamnoglycoside of Diosmetin. Capillary protectant. References Damon, M., et al.: Arzneim.-Forsch., 37, 1149 (1987), Laurent, R., et al.: Int. Angiol., 7, 39 (1988), Tajana, A., et al.: Minerva Med., 79, 387 (1988),

Gentamicin B1 is a gentamicin antibiotic that is used to treat skin cancer. It inhibits bacterial growth by binding to the 50S ribosomal subunit and blocking protein synthesis. Gentamicin B1 has shown clinical response in patients with wild-type strains of Streptococcus faecalis, but not in those with a mutant strain. The mechanism of action for this drug may involve its ability to inhibit epidermal growth factor (EGF) production. Gentamicin B1 also has been shown to inhibit the proliferation of human cancer cells and induce apoptosis in some tumor cells.

Please enquire for more information about 1-[[2-[(2-Aminophenyl)amino]-5-methyl-3-thienyl]carbonyl]-4-methyl-piperazine including the price, delivery time and more detailed product information at the technical inquiry form on this page

Dibenzosuberone is a reactive, surfactant, and β-catenin inhibitor that has been shown to have anti-cancer activity against solid tumours. It is synthesized by the asymmetric synthesis of dibenzoyl-L-tartaric acid with sodium dodecylsulfate in the presence of light. The substrate film is used to increase the rate of reactivity. Dibenzosuberone inhibits the growth of cancer cells by inhibiting cyclic peptide synthesis and blocking light emission from these cells. Dibenzosuberone also has an effect on cell migration and proliferation through its interactions with β-catenin. Dibenzosuberone hydrolyzes in aqueous solution to form benzene, which can be removed by adding hydrochloric acid or hydrogen bonding with anhydrous sodium.

Please enquire for more information about Terbuchlor including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about 6-Hydroxy-4’-tert-butyldimethylsylyl raloxifene-d4 including the price, delivery time and more detailed product information at the technical inquiry form on this page

2,6-Dichlorophenyl carbonimidic dichloride is an analytical reference material that is used as a high purity and drug development API impurity standard. The compound has been found to be a metabolite of the anti-inflammatory drug ibuprofen. It is also used as a pharmacopoeia impurity standard in the United States, Japan, and Europe. CAS No. 21709-18-2 is the assigned number for this compound.

Please enquire for more information about 4-[(3-Chlorophenyl)sulfonyl]benzenamine including the price, delivery time and more detailed product information at the technical inquiry form on this page

Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoi

Please enquire for more information about 5-Chloro-2-(4-chlorophenoxy)phenol 1-acetate including the price, delivery time and more detailed product information at the technical inquiry form on this page

Applications 2-Quinoxalinecarboxylic Acid-d4 is labelled 2-Quinoxalinecarboxylic Acid (Q765265) which is a residue of Carbadox (C175825), an antimicrobial drug. References Hutchinson, M., et al.: Food Addit. Contam., 21, 538 (2004); Thrasher, et al.: J. Anim. Sci., 26, 911 (1967)